Audit of state-funded antiviral treatment for chronic hepatitis C in Qatar
AbstractHepatitis C virus [HCV] infection is a major public health problem in the Middle East. A database of 400 patients with chronic HCV in Qatar was retrospectively analysed: 242 patients underwent antiviral treatment, of whom 212 [87.6%] were naive to treatment. The response to treatment and the predictors of response were studied. The largest group of patients were of Egyptian origin. The rate of sustained virological response [SVR] varied significantly between patients with HCV genotypes 2 or 3 [79.6%] and genotype 1 [45.6%] and 4 [the predominant genotype] [51.0%]. Multivariate analysis showed that the independent predictors of SVR were age < 45 years, infection with genotypes 2 or 3, low fibrosis score on liver biopsy and naive treatment status
John, A.K., Al Kaabi, S., John, A., Singh, R. & Derbala, M. (2010). Audit of state-funded antiviral treatment for chronic hepatitis C in Qatar. EMHJ - Eastern Mediterranean Health Journal, 16 (11), 1121-1127, 2010 https://apps.who.int/iris/handle/10665/118039
JournalEMHJ - Eastern Mediterranean Health Journal, 16 (11), 1121-1127, 2010
MetadataShow full item record
Showing items related by title and subject
Genotype characterization of occult hepatitis B virus strains among Egyptian chronic hepatitis C patients Kishk, R.; Aboul Atta, H.; Ragheb, M.; Kamel, M.; Metwally, L.; Nemr, N. (World Health Organization, Regional Office for the Eastern Mediterranean, 2014)Chronic hepatitis C virus [HCV]infection combined with occult hepatitis B virus [HBV]infection has been associated with increased risk of hepatitis, cirrhosis and hepatocellular carcinoma.This study aimed to determine the ...
Peginterferon alfa-2b and ribavirin therapy in Kuwaiti patients with chronic hepatitis C virus infection Al Enzi, S.A.; Ismail, W.A.; Alsurayei, S.A.; Ismail, A.E. (2011)Few studies have been conducted in the Eastern Mediterranean region on chronic hepatitis C virus [HCV] infection with reference to genotypes. We investigated the response to standard combination therapy [pegylated ...